DC Field | Value | Language |
dc.contributor.author | Grosu, A. | |
dc.contributor.author | Raducan, A. | |
dc.date.accessioned | 2020-05-06T20:22:43Z | |
dc.date.available | 2020-05-06T20:22:43Z | |
dc.date.issued | 2012 | |
dc.identifier.citation | GROSU, A.; RĂDUCAN, A. Tahiaritmiile ventriculare: diagnostic şi tratament. In: Curierul Medical. 2012, nr. 4(328), pp. 64-69. ISSN 1875-0666. | en_US |
dc.identifier.issn | 1875-0666 | |
dc.identifier.uri | http://moldmedjournal.md/wp-content/uploads/2016/09/19.pdf | |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/9145 | |
dc.description | Department of Emergency and Cardiac Rhythm Disorders, Institute of Cardiology, Chisinau, Republic of Moldova | en_US |
dc.description.abstract | One of the most important problems in intensive care and emergencies involves patients with life-threatening cases of Ventricular Tachyarrhythmia.
The goal in management of this serious problem is to avoid sudden cardiac death. The term “ventricular arrhythmias” incorporates a wide spectrum
of abnormal cardiac rhythms, from single premature ventricular complexes to sustained monomorphic/polymorphic Ventricular Tachycardia, and
ventricular fibrillation. Sustained ventricular arrhythmias are the most common cause of sudden cardiac death. These arrhythmias occur predominantly
in patients with structural heart disease, but are also seen in patients without demonstrable cardiac disease. The purpose of the present article is to review
etiology and summarize new strategies of diagnosis and treatment of Ventricular Tachyarrhythmia. It describes modern methods of diagnostics and the
significance of treatment using beta-blockers (rizoprol), amiodaronе (rotaritmil) and antiplatelet drug (lopigrol). | en_US |
dc.description.abstract | Данная статья представляет современные сведения об этиологии, диагностике и лечении злокачественных желудочковых тахиаритмий.
Рассматриваются основные причины возникновения этих жизнеугрожающих нарушений ритма ишемическая болезнь сердца, продолжая
оставаться одним из главных провоцирующих субстратов (75%). Описаны современные методы диагностики, лечения с применением бетаблокаторов, амиодарона (ризопрол, ротаритмил) и вторичной профилактики ишемической болезни сердца (лопигрол). | |
dc.language.iso | ro | en_US |
dc.publisher | Ministerul Sănătăţii al Republicii Moldova, Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” | en_US |
dc.subject | ventricular tachyarrhythmia | en_US |
dc.subject | etiology | en_US |
dc.subject | diagnosis | en_US |
dc.subject | treatment | en_US |
dc.subject.mesh | Tachycardia--diagnosis | en_US |
dc.subject.mesh | Tachycardia--etiology | en_US |
dc.subject.mesh | Tachycardia--drug therapy | en_US |
dc.subject.mesh | Arrhythmias, Cardiac--drug therapy | en_US |
dc.subject.mesh | Arrhythmias, Cardiac--diagnosis | en_US |
dc.subject.mesh | Arrhythmias, Cardiac--etiology | en_US |
dc.subject.mesh | Anti-Arrhythmia Agents--therapeutic use | en_US |
dc.subject.mesh | Adrenergic beta-Antagonists--therapeutic use | en_US |
dc.title | Tahiaritmiile ventriculare: diagnostic şi tratament | en_US |
dc.title.alternative | Ventricular tachyarrhythmia: diagnosis and treatment | en_US |
dc.title.alternative | Желудочковые тахиаритмии: диагностика и лечение | en_US |
dc.type | Article | en_US |
Appears in Collections: | Curierul Medical, 2012, Vol. 328, Nr. 4
|